Wambeke David J.

Average Profitability
23.22%
Insider Buys Quantity
3
Insider Buys Sum
$949,203.24
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Wambeke David J.

According to the SEC Form 4 filings, Wambeke David J., being in a position of

  1. Chief Business Officer at DiaMedica Therapeutics Inc.,
    оver the last 12 months, has bought 20000 shares for $49,200, and sold 0 shares,
    over all time since 2023-04-10, has bought 527114 shares for $949,203, and sold 0 shares.

The largest purchase of all time was on 2023-04-10 and amounted to 468750 shares of DiaMedica Therapeutics Inc. for $750,000.

Biography of Wambeke David J.

No biography is available at this moment.

2023-11-16PurchaseDiaMedica Therapeutics Inc.
DMAC
Chief Business Officer
20,000
0.0542%
$2.46$49,200+22.59%
2023-06-23PurchaseDiaMedica Therapeutics Inc.
DMAC
Chief Business Officer
38,364
0.1334%
$3.91$150,003-33.18%
2023-04-10PurchaseDiaMedica Therapeutics Inc.
DMAC
Chief Business Officer
468,750
1.8065%
$1.60$750,000+79.62%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.